Why Ozempic Sometimes Doesn't Work
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
Why Ozempic Sometimes Doesn't Work
-
Gesprochen von:
-
Von:
Why Ozempic Doesn’t Work for Everyone: The DNA Clue
This episode explains why Ozempic and similar weight-loss drugs don’t work the same for everyone, highlighting a Stanford University study published in April 2026. Researchers found that about 10% of people carry variants in a single gene affecting the enzyme PAM, which helps activate the body’s natural GLP-1 hormone—the system these medications rely on. With a sluggish PAM “switch,” GLP-1 may not be properly activated, which could help explain why some patients lose a lot of weight while others see minimal results. The host offers three takeaways: lack of response may not be willpower-related, genetic testing may eventually guide drug choice, and non-responders should discuss alternatives like SGLT2 inhibitors with a doctor. The episode notes this is early research and no approved predictive test exists yet.
00:00 Welcome and Setup
00:20 Ozempic Works Differently
00:43 The Gene Behind Response
01:18 Why GLP-1 Drugs Vary
01:38 Three Key Takeaways
02:17 Early Research Caveats
02:40 Wrap Up and Share